X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
index medicus (47) 47
infectious diseases (40) 40
male (38) 38
hiv (35) 35
adult (32) 32
female (32) 32
middle aged (26) 26
immunology (24) 24
hepatitis c (23) 23
hiv infections - complications (23) 23
hiv infections - drug therapy (22) 22
hepatitis (17) 17
human immunodeficiency virus--hiv (16) 16
human-immunodeficiency-virus (15) 15
antiretroviral therapy (13) 13
antiviral agents - therapeutic use (13) 13
infections (13) 13
virology (13) 13
aids/hiv (12) 12
coinfection (12) 12
treatment outcome (12) 12
hepatitis c virus (11) 11
viral load (11) 11
antiviral agents (10) 10
cohort studies (10) 10
hcv (10) 10
health aspects (10) 10
hepatitis c - virology (10) 10
hiv infections - epidemiology (10) 10
infection (10) 10
mortality (10) 10
virus diseases (10) 10
active antiretroviral therapy (9) 9
epidemiology (9) 9
genotype (9) 9
prevalence (9) 9
aids (8) 8
antiretroviral therapy, highly active (8) 8
cd4 lymphocyte count (8) 8
coinfection - drug therapy (8) 8
disease (8) 8
hepacivirus - genetics (8) 8
human immunodeficiency virus (8) 8
infected patients (8) 8
liver diseases (8) 8
risk factors (8) 8
therapy (8) 8
viruses (8) 8
cirrhosis (7) 7
drug therapy (7) 7
hepacivirus - classification (7) 7
hepatitis b (7) 7
hepatitis c - drug therapy (7) 7
highly active antiretroviral therapy (7) 7
hiv infections - virology (7) 7
liver (7) 7
microbiology (7) 7
ribavirin (7) 7
united kingdom - epidemiology (7) 7
abridged index medicus (6) 6
acquired immune deficiency syndrome--aids (6) 6
aged (6) 6
anti-retroviral agents - therapeutic use (6) 6
comorbidity (6) 6
drug therapy, combination (6) 6
fibrosis (6) 6
gastroenterology & hepatology (6) 6
hepatitis c - complications (6) 6
hepatitis c, chronic - drug therapy (6) 6
hiv infection (6) 6
interferon (6) 6
pegylated interferon-alpha (6) 6
prospective studies (6) 6
sustained virological response (6) 6
africa (5) 5
analysis (5) 5
care and treatment (5) 5
cohort (5) 5
europe (5) 5
guidelines (5) 5
hepatitis c - epidemiology (5) 5
hepatitis c, chronic - complications (5) 5
hiv patients (5) 5
infectious disease (5) 5
liver cirrhosis (5) 5
medical research (5) 5
medicine (5) 5
men (5) 5
outcomes (5) 5
research (5) 5
ribavirin - therapeutic use (5) 5
sex (5) 5
united kingdom (5) 5
acute disease (4) 4
adolescent (4) 4
aids-related opportunistic infections - drug therapy (4) 4
anti-hiv agents - therapeutic use (4) 4
antiretroviral drugs (4) 4
complications and side effects (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 498 - 503
Journal Article
BMJ (Online), ISSN 0959-8146, 2018, Volume 363, p. k4041
Journal Article
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 04/2018, Volume 21, Issue S2, pp. e25076 - n/a
Introduction: The introduction of drugs targeting the virus replication cycle has revolutionized treatment of chronic hepatitis C virus. These drugs, called... 
Hepatitis | HCV | Coinfection | Safety | Baseline | DAA | INFECTIOUS DISEASES | EFFICACY | IMMUNOLOGY | HIV/HCV COINFECTION | HCV INFECTION | REGIMENS | CHALLENGES | SUSTAINED VIROLOGICAL RESPONSE | HEPATITIS-C VIRUS | CIRRHOSIS | DRUGS | KIDNEY | Antiviral agents | Care and treatment | Liver diseases | Hepatitis C virus | Comorbidity | Liver | Genotype & phenotype | Ultrasonic imaging | Surveillance | Mortality | Infections | Interferon | Endoscopy
Journal Article
Journal of travel medicine, ISSN 1708-8305, 06/2019, Volume 26, Issue 5
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2019, Volume 80, Issue 4, pp. 474 - 480
BACKGROUND:Spectrum of liver injury among HIV-positive people is wide; in particular, prevalence of nonalcoholic fatty liver disease (NAFLD) seems to be higher... 
INFECTIOUS DISEASES | METABOLIC SYNDROME | RISK-FACTORS | PREVALENCE | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | HEPATIC-FIBROSIS | TRANSIENT ELASTOGRAPHY | INDIVIDUALS | liver fibrosis | HIV | FIB4 | STEATOSIS | liver histology | FibroScan | INFECTED PATIENTS | VIRAL-HEPATITIS | Fatty liver | Liver diseases | Etiology | Liver | Human immunodeficiency virus--HIV | Transaminases | Fibrosis | Stiffness | Histology | Diagnostic systems
Journal Article
World Journal of Hepatology, ISSN 1948-5182, 2015, Volume 7, Issue 15, pp. 1936 - 1952
A substantial proportion of individuals with chronic hepatitis C virus (HCV) are co-infected with human immunodeficiency virus (HIV). Co-infected individuals... 
Antiviral agents | Therapy | Anti-retroviral agents | Coinfection | Pathogenesis | Human immunodeficiency virus | Hepatitis C | Epidemiology | Natural history
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 12/2018, Volume 25, Issue 12, pp. 1438 - 1445
The World Health Organisation has recently called for hepatitis C virus ( HCV ) elimination and has identified people who inject drugs ( PWID ) as a key... 
hepatitis C virus | fibrosis | Sub‐Saharan Africa | cascade of care | people who inject drugs | Sub-Saharan Africa | PLATELET RATIO | INFECTIOUS DISEASES | INFECTIONS | PREVALENCE | HARM REDUCTION | TRANSIENT ELASTOGRAPHY | VIROLOGY | HIV | LIVER FIBROSIS ASSESSMENT | DISEASE | HCV | USERS | GASTROENTEROLOGY & HEPATOLOGY | Drugs | RNA | Analysis | Hepatitis C virus | Hepatitis C | Epidemiology | Liver cirrhosis | Original
Journal Article